Clinical Trial

Rhythmic Auditory Stimulaton Using Personalized Music Therapy in Parkinson's Disease

Study acronym: RASP-PD
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 30, 2026 (before its estimated April 5, 2026 completion). Its status may not reflect the trial's current state.
Summary
Parkinson's disease (PD) is a progressive neurodegenerative disorder commonly associated with gait disturbances, balance impairments, and freezing of gait, which significantly increase the risk of falls and reduce functional independence. Conventional physical therapy improves mobility in individuals with PD; however, persistent gait deficits often remain. Rhythmic Auditory Stimulation (RAS) is an emerging, evidence-based intervention that uses external auditory cues to enhance gait timing, stride length, and movement initiation. This randomized controlled trial aims to evaluate the effectiveness of rhythmic auditory stimulation using personalized music therapy combined with conventional physical therapy compared to conventional physical therapy alone in individuals with Parkinson's disease. The primary outcomes include freezing of gait, gait velocity, and balance performance. Forty-two clinically diagnosed Parkinson's disease patients will be randomly allocated into two groups. Group A will receive conventional physical therapy, while Group B will receive rhythmic auditory stimulation using personalized music in addition to conventional therapy over an 8-week intervention period. The findings of this study may provide clinical evidence supporting the integration of personalized rhythmic auditory stimulation into rehabilitation programs for improving gait and balance in individuals with Parkinson's disease.
Trial Details
NCT Number NCT07378722
Lead Sponsor Rumesa Butt
Conditions Parkinson s Disease
Enrollment 50 participants
Start Date 2026-02-05
Primary Completion 2026-04-05 (estimated)
Study Completion 2026-04-06 (estimated)
Updated on ClinicalTrials.gov 2026-01-30